Endo International plc is 10% Owner at BIOSPECIFICS TECHNOLOGIES CORP (BSTC). They have made 1 open-market trade across 1 company since 2020, most recently 2020-12-02.
CIK 0001593034
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.3B since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BSTC | 100 | $9K |
Shares reported on the most recent Form 4, priced at the 2020-12-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BSTC | BUY | 2020-12-02 | 2020-12-08 | $88.50 | $1.3B | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.